Physician profile
Erich Gottwald
NPI 1811155047
$1,453.35
in general payments reported to CMS, 2019-2025
20 companies · $26.84 in 2025
The $26.84 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $20.42 · 2021: $17.35 · 2022: $60.66 · 2025: $26.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $393.99 | 2019 | |
| Medtronic USA, INC. | $202.93 | 2019 | |
| Si-Bone, INC. | $184.31 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $111.84 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.96 | 2019 | |
| Abbott Laboratories | $75.37 | 2019 | |
| Collegium Pharmaceutical, INC. | $60.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $49.96 | 2019 | |
| Biodelivery Sciences International, INC. | $46.19 | 2019 | |
| Medtronic, INC. | $39.60 | 2022-2025 | Inceptiv |
| Treace Medical Concepts, INC. | $27.68 | 2022 | |
| Boston Scientific Corporation | $23.18 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.42 | 2020 | |
| Lilly USA, LLC | $20.31 | 2019 | |
| Nevro Corp. | $19.13 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $18.31 | 2019 | |
| Kci USA, INC. | $17.35 | 2021 | |
| Shionogi INC | $16.56 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.93 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erich Gottwald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.